Effects of Angiotensin Converting Enzyme Inhibitors on Liver Fibrosis in HIV and Hepatitis C Coinfection

por Reese, Lindsey J., Tider, Diane S., Stivala, Alicia C., Fishbein, Dawn A.
Publicado 2012

Leveraging the electronic health record to eliminate hepatitis C: Screening in a large integrated healthcare system

por Geboy, Alexander G., Nichols, Whitney L., Fernandez, Stephen J., Desale, Sameer, Basch, Peter, Fishbein, Dawn A.
Publicado 2019

HIV testing in patients who are HCV positive: Compliance with CDC guidelines in a large healthcare system

por Fleisher, Ilan, Geboy, Alexander G., Nichols, Whitney, Desale, Sameer, Fernandez, Stephen, Basch, Peter, Fishbein, Dawn A.
Publicado 2021

2354: Pioneering the pathway with big data to eliminate hepatitis C viral infection (EHCV)

por Fishbein, Dawn A, Brooks, Ian, Villa Baca, Emanuel, Ozmen, Ozgur, Shankar, Mallikarjun, Weigand, Gil, Thiagarajan, Kristina, Estes, Randy, Geboy, Alex, Deeb, Hala, Jain, Mamta, Miller, Lesley
Publicado 2018

A Pragmatic, Randomized Controlled Trial of Oral Antivirals for the Treatment of Chronic Hepatitis C: The PRIORITIZE Study

por Sulkowski, Mark S., Moon, Juhi S., Sherman, Kenneth E., Morelli, Giuseppe, Darling, Jama M., Muir, Andrew J., Khalili, Mandana, Fishbein, Dawn A., Hinestrosa, Federico, Shiffman, Mitchell L., Di Bisceglie, Adrian, Reddy, K. Rajender, Pearlman, Brian, Lok, Anna S., Fried, Michael W., Stewart, Paul W., Peter, Joy, Wadsworth, Summer, Kixmiller, Scott, Sloan, Anquenette, Vainorius, Monika, Horne, Patrick M., Michael, Larry, Dong, Meichen, Evon, Donna M., Segal, Jodi B., Nelson, David R.
Publicado 2021